Siga Technologies (SIGA) Gross Margin (2017 - 2025)
Siga Technologies' (SIGA) quarterly Gross Margin came in at 61.75% in Q3 2025, down 2206.0% on a YoY basis from 2.93% in Q3 2024, and down 9.85% quarter-over-quarter from 68.5% in Q2 2025.
Analysis
Siga Technologies (SIGA) Gross Margin (2017 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Gross Margin for 9 consecutive years, with 61.75% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Gross Margin fell 2206.0% year-over-year to 61.75%; the trailing twelve-month figure through Sep 2025 stood at 76.29% (down 532.0% YoY), and the FY2024 full-year result was 77.44%, down 982.0% from the prior year.
- Gross Margin declined to 61.75% in Q3 2025 per SIGA's latest filing, from 68.5% in the prior quarter.
- Across five years, Gross Margin topped out at 98.28% in Q3 2021 and bottomed at 43.55% in Q2 2024.
- Historically, Gross Margin has averaged 83.03% across 5 years, with a median of 87.29% in 2023.
- The sharpest annual moves came in 2023 and 2024: Gross Margin surged 3097 bps in 2023, then plunged 3987 bps in 2024.
- Over 5 years, Gross Margin stood at 86.76% in 2021, then advanced by 6 bps to 92.24% in 2022, then retreated by 5 bps to 87.29% in 2023, then declined by 5 bps to 82.65% in 2024, then declined by 25 bps to 61.75% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 61.75%, 68.5%, and 97.76% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 78.02% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 72.78% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 80.05% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 93.73% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 87.30% |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 61.75% |
| Jun 30, 2025 | 68.50% |
| Mar 31, 2025 | 97.76% |
| Dec 31, 2024 | 82.65% |
| Sep 30, 2024 | 83.81% |
| Jun 30, 2024 | 43.55% |
| Mar 31, 2024 | 87.32% |
| Dec 31, 2023 | 87.29% |
| Sep 30, 2023 | 90.29% |
| Jun 30, 2023 | 83.42% |
| Mar 31, 2023 | 86.18% |
| Dec 31, 2022 | 92.24% |
| Sep 30, 2022 | 94.53% |
| Jun 30, 2022 | 94.71% |
| Mar 31, 2022 | 55.21% |
| Dec 31, 2021 | 86.76% |
| Sep 30, 2021 | 98.28% |
| Jun 30, 2021 | 88.49% |
| Mar 31, 2021 | 94.79% |
| Dec 31, 2020 | 88.52% |